Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale
Go back to Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale| (NYSE: BHVN) | Delayed: 14.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.22 | 52 Week High | $ | |||
| Open | $14.22 | 52 Week Low | $ | |||
| Day High | $14.22 | P/E | N/A | |||
| Day Low | $14.22 | EPS | $ | |||
| Volume | 250 | |||||
